Designates Carbapenem-resistent Enterobacteriaceae (CRE) as a communicable disease, and requires general hospitals to identify, track and report upon such disease.
Ayes (63): Adams, Addabbo, Avella, Ball, Bonacic, Boyle, Breslin, Carlucci, DeFrancisco, Diaz, Dilan, Espaillat, Farley, Felder, Flanagan, Fuschillo, Gallivan, Gianaris, Gipson, Golden, Griffo, Grisanti, Hannon, Hassell-Thomps, Hoylman, Kennedy, Klein, Krueger, Lanza, Larkin, Latimer, LaValle, Libous, Little, Marcellino, Marchione, Martins, Maziarz, Montgomery, Nozzolio, O'Brien, O'Mara, Parker, Peralta, Perkins, Ranzenhofer, Ritchie, Rivera, Robach, Sampson, Sanders, Savino, Serrano, Seward, Skelos, Smith, Squadron, Stavisky, Stewart-Cousin, Tkaczyk, Valesky, Young, Zeldin
TITLE OF BILL: An act to amend the public health law, in relation to designating Carbapenem-resistant Enterobacteriaceae (CRE) as a communicable disease and requiring general hospitals to identify and track the incidence of such communicable disease in accordance with the hospital acquired infection reporting system
PURPOSE: Designates Carbapenem-resistant Enterobacteriaceae (CRE) as a communicable disease, and requires physicians, hospitals, or institutions to identify, track, and report upon such disease.
SUMMARY OF PROVISIONS:
Section one amends Article 21 of the Public Health Law by adding a new Title eight. Section 2180 of Title eight requires the Commissioner to designate CRE as a communicable disease in the sanitary code and requires general hospitals to track each incidence of CRE and report such incidences on a monthly basis to the department in accordance with the state's hospital acquired infection reporting system.
Section two amends § 2819 of the Public Health Law to include CRE as a hospital acquired infection.
Section three states the effective date.
JUSTIFICATION: The Center for Disease Control has called CRE the "nightmare bacteria," and issued a March 2013 report calling for rapid action. CRE bacteria are difficult to treat because they are resistant to commonly used antibiotics. Some CRE bacteria have become resistant to almost all available antibiotics and can be deadly-one report cites they can contribute to death in up to 50% of patients who become infected. Further, CRE can turn other bacteria in the body into drug-resistant bacteria as well.
CRE infections are most commonly seen in sick patients with exposure to health care settings like hospitals and long-term care facilities, such as skilled nursing facilities, and long-term acute care hospitals. Patients whose care requires devices like ventilators, urinary catheters, or intravenous catheters, and patients who are taking long courses of certain antibiotics are among those most at risk for CRE infections. Bacteria are spread by person-to person contact, mostly via hands. The CDC has urged doctors, hospital leaders and public health professionals to work together to implement the CDC's "detect and protect" strategy to stop these infections from spreading. One such measure is the reporting by medical facilities of any instances of CRE.
This legislation responds to the CDC's suggested strategies by making mandatory the reporting of CRE. Cases of CRE should be reported and track by the Department of Health to adequately address incidences and ensure appropriate control measures are being taken. New York already has systems in place to track and report other communicable diseases and hospital acquired infections and is in a good position to add CRE to that process. By adopting this legislation, New York will join the six other states requiring medical facilities to report incidences of
CRE. By doing so, we can halt the spread of this potentially deadly bacteria.
LEGISLATIVE HISTORY: New bill.
FISCAL IMPLICATIONS: None.
EFFECTIVE DATE: This act shall take effect immediately.
STATE OF NEW YORK ________________________________________________________________________ 4414 2013-2014 Regular Sessions IN SENATE March 26, 2013 ___________Introduced by Sen. HANNON -- read twice and ordered printed, and when printed to be committed to the Committee on Health AN ACT to amend the public health law, in relation to designating Carba- penem-resistant Enterobacteriaceae (CRE) as a communicable disease and requiring general hospitals to identify and track the incidence of such communicable disease in accordance with the hospital acquired infection reporting system THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Article 21 of the public health law is amended by adding a new title 8 to read as follows: TITLE 8 CARBAPENEM-RESISTANT ENTEROBACTERIACEAE SECTION 2180. DESIGNATION AS COMMUNICABLE DISEASE; GENERAL HOSPITAL REPORTING. S 2180. DESIGNATION AS COMMUNICABLE DISEASE; GENERAL HOSPITAL REPORT- ING. 1. THE COMMISSIONER SHALL DESIGNATE AS A COMMUNICABLE DISEASE AND INCLUDE AS SUCH IN THE SANITARY CODE, CARBAPENEM-RESISTANT ENTEROBACTER- IACEAE (CRE). SUCH DISEASE SHALL BE SUBJECT TO THE PROVISIONS OF THIS ARTICLE WHICH ARE APPLICABLE TO OTHER COMMUNICABLE DISEASES. 2. EVERY GENERAL HOSPITAL SHALL IDENTIFY AND TRACK EACH INCIDENT OF CARBAPENEM-RESISTANT ENTEROBACTERIACEAE, AND SHALL, ON A MONTHLY BASIS, REPORT EACH SUCH INCIDENT TO THE DEPARTMENT. FURTHERMORE, THE DEPARTMENT SHALL INCLUDE CARBAPENEM-RESISTANT ENTEROBACTERIACEAE IN ITS REGULATIONS REQUIRING GENERAL HOSPITALS TO IDENTIFY, TRACK AND REPORT HOSPITAL ACQUIRED INFECTIONS PURSUANT TO SECTION TWENTY-EIGHT HUNDRED NINETEEN OF THIS CHAPTER. S 2. Subdivision 1 of section 2819 of the public health law is amended by adding a new closing paragraph to read as follows: SUCH TERM SHALL ALSO INCLUDE CARBAPENEM-RESISTANT ENTEROBACTERIACEAE (CRE). S 3. This act shall take effect immediately.EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD10097-01-3